国际检验医学杂志
國際檢驗醫學雜誌
국제검험의학잡지
INTERNATIONAL JOURNAL OF LABORATORY MEDICINE
2009年
11期
1068-1069
,共2页
漆明%李勇文%蒋庆军%韦海春%蒋瑜采
漆明%李勇文%蔣慶軍%韋海春%蔣瑜採
칠명%리용문%장경군%위해춘%장유채
上皮细胞%DNA探针,HPV%宫颈肿瘤%细胞学%诊断
上皮細胞%DNA探針,HPV%宮頸腫瘤%細胞學%診斷
상피세포%DNA탐침,HPV%궁경종류%세포학%진단
Epithelial cells%DNA probes,HLA%Uterine cervical neoplasms%Cytology%Diagnosis
目的 探讨非典型鳞状上皮细胞(ASC)的临床意义及其进一步处理方法.方法 对348例宫颈细胞学检查诊断为ASC的患者行阴道镜下多点活检术,同时采用荧光定量PCR法检测HPV DNA含量.结果 组织活检CIN Ⅰ~Ⅲ85例,炎症263例;HPV DNA阳性84例、阴性264例.高危型HPV DNA阳性标本中CINⅡ~Ⅲ的检出率明显高于HPV阴性标本(P<0.01),高危型HPV DNA的阴性预测值为99.0%.结论 ASC患者应联合检测HPV,高危型HPV DNA阳性者应直接行阴道镜活检,进一步明确诊断.高危型HPV DNA检测对宫颈CIN有更好的预测价值.
目的 探討非典型鱗狀上皮細胞(ASC)的臨床意義及其進一步處理方法.方法 對348例宮頸細胞學檢查診斷為ASC的患者行陰道鏡下多點活檢術,同時採用熒光定量PCR法檢測HPV DNA含量.結果 組織活檢CIN Ⅰ~Ⅲ85例,炎癥263例;HPV DNA暘性84例、陰性264例.高危型HPV DNA暘性標本中CINⅡ~Ⅲ的檢齣率明顯高于HPV陰性標本(P<0.01),高危型HPV DNA的陰性預測值為99.0%.結論 ASC患者應聯閤檢測HPV,高危型HPV DNA暘性者應直接行陰道鏡活檢,進一步明確診斷.高危型HPV DNA檢測對宮頸CIN有更好的預測價值.
목적 탐토비전형린상상피세포(ASC)적림상의의급기진일보처리방법.방법 대348례궁경세포학검사진단위ASC적환자행음도경하다점활검술,동시채용형광정량PCR법검측HPV DNA함량.결과 조직활검CIN Ⅰ~Ⅲ85례,염증263례;HPV DNA양성84례、음성264례.고위형HPV DNA양성표본중CINⅡ~Ⅲ적검출솔명현고우HPV음성표본(P<0.01),고위형HPV DNA적음성예측치위99.0%.결론 ASC환자응연합검측HPV,고위형HPV DNA양성자응직접행음도경활검,진일보명학진단.고위형HPV DNA검측대궁경CIN유경호적예측개치.
Objective To explore the clinical significance of atypical squamous cells (ASC) and the further dealing method. Methods Multipoint biopsies under colposcope was applied to the 348 patients. At the same time,the content of HPV-DNA detected with FQ-PCR. Results Totally 85 cases among them were CIN Ⅰ-Ⅲ, 263 cases were determined as imflammation, 84 cases were determined as HPV-DNA-positive, and 264 cases were HPV-DNA negative. Compared with that of the specimens with HPV negative, CIN Ⅰ-Ⅲ detection rate of the specimens of HPV-DNA with high risk was significantly higher (P<0. 01). The negativen predictive value of high-risk type HPV-DNA was 99. 0%. Conclusion The patients with HPV-DNA positive should receive biopsies under colposcope so as to acquire final diagnosis. It is necessary for patients with ASC to receive HPV-DNA detection. Detection of HPV-DNA with high risk may have more forecasting value to cervical intra-epithelial neoplasia (CIN).